Press / Health Care

Press

By / 6.20.2018

Two weeks ago, the U.S. Department of Justice (DOJ) filed a legal brief in support of a Texas lawsuit that would kill one of the most popular provisions of the Affordable Care Act (ACA): the one that ensures people with past medical problems can get affordable health insurance. It’s the latest twist in the Trump administration’s unrelenting […]

By / 6.7.2018

Lynnel Beauchesne’s dental office hugs a rural crossroads near Tunnelton, W.Va., population 336. Acres of empty farmland surround the weathered one-story white building; a couple of houses and a few barns are the only neighbors. But the parking lot is full. Some people have driven hours to see Beauchesne, the sole dentist within 30 miles. […]

By / 5.8.2018

In the future, medicine will be tailored to your individual “genome” or genetic code, lifestyle and community. Rather than a one-size-fits-most treatment, doctors will use data to determine what therapies you should receive based on genetic traits you’ve inherited from family, your daily habits, and where you live. But how do we get there? We […]

By / 3.22.2018

Under Gov. Gina Raimondo, Rhode Island is aiming to rebuild its economy — once factory-based — around advanced industries​​ such as biotech and software. With such projects as the Providence Innovation & Design District, the goal is to create good-paying jobs by attracting leading-edge companies to the state. How odd, then, that the state legislature […]

By / 12.19.2017

It’s been a surreal political year, but PPI has much to celebrate this holiday season. Throughout 2017, we expanded our productive capacity and the scope of our political and media outreach significantly. For example, PPI organized 150 meetings with prominent elected officials; visited 10 state capitals and 10 foreign capitals, published an influential book and […]

By / 1.27.2017

“Have your cake and eat it.”  With these six aggressively monosyllabic words, the redoubtable Boris Johnson came clean, almost despite himself, about the contradictions of Brexit, and perhaps those of today’s right-of-center populism altogether.  In time, the phrase may be seen as the defining utterance of the post-truth era in trans-Atlantic politics. The Washington corollary […]

By / 12.11.2015

An unfortunate refrain among Democratic presidential hopefuls is that rapacious pharmaceutical and biotech companies are driving up the cost of essential medications, bankrupting the health-care system, and depriving sick Americans of treatment. Hillary Clinton has honed her message to a nice sound bite: Drug companies that charge excessively high prices “are making a fortune off […]

By / 6.19.2015

As the presidential campaign season gets underway, it reminds us how much we loath the politics of fear mongering. Half-truths and half-baked policy proposals have become staples of modern campaigns. You betcha! Until recently, there was a difference between campaigning and governing. Governments are supposed to base their decisions on hard facts and real science. […]

By / 5.11.2015

The Food and Drug Administration (FDA) is fast finding itself at the center of the debate over healthcare regulation in the 21st century. At issue: to embrace the power of data-driven innovation, or to stand by the current regulatory paradigm. Fortunately, two major Congressional initiatives may be the push the FDA needs to see the […]

WASHINGTON—The amount of regulation on the pharmaceutical industry has increased 40 percent since 2000, according to a policy memo released today by the Progressive Policy Institute (PPI). Moreover, some new draft regulations proposed by the Food and Drug Administration (FDA) this year fail to embrace data-driven innovation. In FDA Regulation in the Data-Driven Economy, PPI […]